These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24098086)

  • 1. Cost of noninfectious comorbidities in patients with HIV.
    Guaraldi G; Zona S; Menozzi M; Carli F; Bagni P; Berti A; Rossi E; Orlando G; Zoboli G; Palella F
    Clinicoecon Outcomes Res; 2013 Sep; 5():481-8. PubMed ID: 24098086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature age-related comorbidities among HIV-infected persons compared with the general population.
    Guaraldi G; Orlando G; Zona S; Menozzi M; Carli F; Garlassi E; Berti A; Rossi E; Roverato A; Palella F
    Clin Infect Dis; 2011 Dec; 53(11):1120-6. PubMed ID: 21998278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact study.
    Guaraldi G; Zona S; Menozzi M; Brothers TD; Carli F; Stentarelli C; Dolci G; Santoro A; Da Silva AR; Rossi E; Falutz J; Mussini C
    AIDS Res Ther; 2017 Feb; 14(1):8. PubMed ID: 28209189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inpatient, Outpatient, and Pharmacy Costs in Patients With and Without HIV in the US Veteran's Affairs Administration System.
    Sutton S; Magagnoli J; Cummings T; Hardin J; Edun B
    J Int Assoc Provid AIDS Care; 2019; 18():2325958219855377. PubMed ID: 31213120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of HIV medical care in the era of highly active antiretroviral therapy.
    Gebo KA; Chaisson RE; Folkemer JG; Bartlett JG; Moore RD
    AIDS; 1999 May; 13(8):963-9. PubMed ID: 10371178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of highly active antiretroviral therapy in South Africa.
    Badri M; Maartens G; Mandalia S; Bekker LG; Penrod JR; Platt RW; Wood R; Beck EJ
    PLoS Med; 2006 Jan; 3(1):e4. PubMed ID: 16318413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER.
    Hill AM; Gebo K; Hemmett L; Löthgren M; Allegri G; Smets E
    Pharmacoeconomics; 2010; 28 Suppl 1():169-81. PubMed ID: 21182350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased medical expenditures for care of HIV-seropositive patients. The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center.
    Mole L; Ockrim K; Holodniy M
    Pharmacoeconomics; 1999 Sep; 16(3):307-15. PubMed ID: 10558042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidences of noninfectious comorbidities among aging populations living with human immunodeficiency virus in Ecuador: a multicenter retrospective analysis.
    Hernández I; Barzallo J; Beltrán S; Castillo A; Cevallos N; Hernández P; López C; Vera R; Yerovi G; Mendoza A; Terán S; Izurieta A; Teran E
    HIV AIDS (Auckl); 2019; 11():55-59. PubMed ID: 31114389
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006.
    Krentz HB; Gill MJ
    HIV Med; 2008 Oct; 9(9):721-30. PubMed ID: 18643856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities and costs in HIV patients: A retrospective claims database analysis in Germany.
    Christensen S; Wolf E; Altevers J; Diaz-Cuervo H
    PLoS One; 2019; 14(11):e0224279. PubMed ID: 31693696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term impact of highly active antiretroviral therapy on HIV-related health care costs.
    Keiser P; Nassar N; Kvanli MB; Turner D; Smith JW; Skiest D
    J Acquir Immune Defic Syndr; 2001 May; 27(1):14-9. PubMed ID: 11404515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV economic burden of illness in the Veterans Health Administration population.
    Wang L; Haider S; Nedrow K; Chambers R; Tawadrous M; Baser O; Simpson KN
    AIDS Care; 2015; 27(1):123-31. PubMed ID: 25225150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of the cost of health services used by veterans with HIV.
    Barnett PG; Chow A; Joyce VR; Bayoumi AM; Griffin SC; Nosyk B; Holodniy M; Brown ST; Sculpher M; Anis AH; Owens DK
    Med Care; 2011 Sep; 49(9):848-56. PubMed ID: 21610542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USA.
    Mauskopf J; Brogan A; Martin S; Smets E
    Pharmacoeconomics; 2010; 28 Suppl 1():83-105. PubMed ID: 21182346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France.
    Pourcher V; Gourmelen J; Bureau I; Bouee S
    PLoS One; 2020; 15(12):e0243529. PubMed ID: 33332394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.
    Leisegang R; Cleary S; Hislop M; Davidse A; Regensberg L; Little F; Maartens G
    PLoS Med; 2009 Dec; 6(12):e1000189. PubMed ID: 19956658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated direct costs of medical care for HIV-infected patients within a regional population from 2006 to 2017.
    Krentz HB; Vu Q; Gill MJ
    HIV Med; 2020 May; 21(5):289-298. PubMed ID: 31852032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.